Health

hyperCORE Welcomes Atlas Clinical Research, Strengthening North American Partner Site Network
Great HealthWorks Earns 2025 Great Place to Work Certification™
IDEAYA Biosciences Announces Successful FDA Type D Meeting on Phase 3 Registrational Trial Design for Darovasertib as Neoadjuvant Therapy for Primary Uveal Melanoma
Chromatin Bioscience unterzeichnet Kollaborationsvertrag mit Astellas
Chromatin Bioscience signe un accord de collaboration avec Astellas
Chromatin Bioscience Signs Collaboration Agreement with Astellas
Invitation to Annual General Meeting 2025
MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor
PRISM BioLab and Elix Join Forces to Accelerate AI-Driven Drug Discovery for Protein-Protein Interaction Targets
AMDI Launches Autolab™ HBH at ESCMID 2025, Redefining Sample Prep for Molecular Diagnostics
Skin cancer patients could join vaccine project
MGI Tech Celebrates 10 Years of DNBSEQ™ Technology: Driving Genomics Forward with Speed, Scale, and Accessibility
CMEF Shanghai 2025 Wraps Up in Shanghai with Record-Breaking Innovations and Global Participation
Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation Salon
Taiwan's ACRO Biomedical Gains Regulatory Approval for Its Collagen Ophthalmic Matrix, Offering New Hope for Corneal Transplant Patients
Lab-grown human teeth to 'fill in the gaps' in regenerative dentistry
Fruitful translation of HKBU's innovative research projects takes centre stage at International Exhibition of Inventions Geneva
Alcohol Justice condena la devastación causada por la eliminación de fondos federales para la prevención del alcoholismo
Three million child deaths linked to drug resistance, study shows
Une étude majeure révèle que plus de 3 millions d'enfants sont morts d'infections liées à la résistance aux antimicrobiens en 2022